Cargando…

Identification of a Cryptic Bacterial Promoter in Mouse (mdr1a) P-Glycoprotein cDNA

The efflux transporter P-glycoprotein (P-gp) is an important mediator of various pharmacokinetic parameters, being expressed at numerous physiological barriers and also in multidrug-resistant cancer cells. Molecular cloning of homologous cDNAs is an important tool for the characterization of functio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pluchino, Kristen M., Esposito, Dominic, Moen, Janna K., Hall, Matthew D., Madigan, James P., Shukla, Suneet, Procter, Lauren V., Wall, Vanessa E., Schneider, Thomas D., Pringle, Ian, Ambudkar, Suresh V., Gill, Deborah R., Hyde, Steven C., Gottesman, Michael M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550409/ https://www.ncbi.nlm.nih.gov/pubmed/26309032 http://dx.doi.org/10.1371/journal.pone.0136396

Ejemplares similares

Mapping discontinuous epitopes for MRK-16, UIC2 and 4E3 antibodies to extracellular loops 1 and 4 of human P-glycoprotein
por: Vahedi, Shahrooz, et al.
Publicado: (2018)

Cryo-EM Analysis of the Conformational Landscape of Human P-glycoprotein (ABCB1) During its Catalytic Cycle
por: Frank, Gabriel A., et al.
Publicado: (2016)

A-803467, a tetrodotoxin-resistant sodium channel blocker, modulates ABCG2-mediated MDR in vitro and in vivo
por: Anreddy, Nagaraju, et al.
Publicado: (2015)

The multidrug resistance transporter P-glycoprotein confers resistance to ferroptosis inducers
por: Frye, William J. E., et al.
Publicado: (2023)

Pharmacophore Modeling of Nilotinib as an Inhibitor of ATP-Binding Cassette Drug Transporters and BCR-ABL Kinase Using a Three-Dimensional Quantitative Structure–Activity Relationship Approach
por: Shukla, Suneet, et al.
Publicado: (2014)

Elucidation of the structural basis of interaction of the BCR-ABL kinase inhibitor, nilotinib (Tasigna(®)) with the human ABC drug transporter P-glycoprotein
por: Shukla, Suneet, et al.
Publicado: (2014)

Glesatinib, a c-MET/SMO Dual Inhibitor, Antagonizes P-glycoprotein Mediated Multidrug Resistance in Cancer Cells
por: Cui, Qingbin, et al.
Publicado: (2019)

Reversing the direction of drug transport mediated by the human multidrug transporter P-glycoprotein
por: Sajid, Andaleeb, et al.
Publicado: (2020)

Raltegravir does not revert efflux activity of MDR1-P-glycoprotein in human MDR cells
por: Dupuis, Maria Luisa, et al.
Publicado: (2013)

Expression of MDR1/P glycoprotein in human sarcomas.
por: Vergier, B., et al.
Publicado: (1993)

Exome Sequencing of ABCB5 Identifies Recurrent Melanoma Mutations that Result in Increased Proliferative and Invasive Capacities
por: Sana, Géraldine, et al.
Publicado: (2019)

Screening Compounds with a Novel High-Throughput ABCB1-Mediated Efflux Assay Identifies Drugs with Known Therapeutic Targets at Risk for Multidrug Resistance Interference
por: Ansbro, Megan R., et al.
Publicado: (2013)

Uncovering cryptic pockets in the SARS-CoV-2 spike glycoprotein
por: Zuzic, Lorena, et al.
Publicado: (2022)

The FLT3 Inhibitor Quizartinib Inhibits ABCG2 at Pharmacologically Relevant Concentrations, with Implications for Both Chemosensitization and Adverse Drug Interactions
por: Bhullar, Jasjeet, et al.
Publicado: (2013)

Catalytic Transitions in the Human MDR1 P-Glycoprotein Drug Binding Sites
por: Wise, John G.
Publicado: (2012)

New mechanisms of multidrug resistance: an introduction to the Cancer Drug Resistance special collection
por: Gottesman, Michael M., et al.
Publicado: (2023)

Intracellular accumulation of punta toro virus glycoproteins expressed from cloned cDNA
por: Matsuoka, Yumiko, et al.
Publicado: (1988)

Selective inhibition of MDR1 P-glycoprotein-mediated transport by the acridone carboxamide derivative GG918
por: Wallstab, A, et al.
Publicado: (1999)

Identification of a Cryptic Prokaryotic Promoter within the cDNA Encoding the 5′ End of Dengue Virus RNA Genome
por: Li, Dongsheng, et al.
Publicado: (2011)

Identification of Cryptic Promoter Activity in cDNA Sequences Corresponding to PRRSV 5′ Untranslated Region and Transcription Regulatory Sequences
por: Chaudhari, Jayeshbhai, et al.
Publicado: (2022)

HIV-1 integrase inhibitors are substrates for the multidrug transporter MDR1-P-glycoprotein
por: Cianfriglia, Maurizio, et al.
Publicado: (2007)

Evidence for the critical role of transmembrane helices 1 and 7 in substrate transport by human P-glycoprotein (ABCB1)
por: Sajid, Andaleeb, et al.
Publicado: (2018)

Multidrug transporters: recent insights from cryo-electron microscopy-derived atomic structures and animal models
por: Lusvarghi, Sabrina, et al.
Publicado: (2020)

Inhibitory Effects of Neochamaejasmin B on P-Glycoprotein in MDCK-hMDR1 Cells and Molecular Docking of NCB Binding in P-Glycoprotein
por: Pan, Lanying, et al.
Publicado: (2015)

Association between 8 P‐glycoprotein (MDR1/ABCB1) gene polymorphisms and antipsychotic drug‐induced hyperprolactinaemia
por: Geers, Lisanne M., et al.
Publicado: (2020)

Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias.
por: Gekeler, V., et al.
Publicado: (1992)

Increased accumulation of doxorubicin and doxorubicinol in cardiac tissue of mice lacking mdr1a P-glycoprotein
por: Asperen, J van, et al.
Publicado: (1999)

Influence of RARα gene on MDR1 expression and P-glycoprotein function in human leukemic cells
por: Stromskaya, Tatjana P, et al.
Publicado: (2005)

Association between MDR1 gene of gastrointestinal tumors, the expression of P-glycoprotein and resistance to chemotherapeutic drugs
por: Su, Jian-Li, et al.
Publicado: (2017)

Quantitative Structure–Activity Relationships for the Flavonoid-Mediated Inhibition of P-Glycoprotein in KB/MDR1 Cells
por: Xia, Mengmeng, et al.
Publicado: (2019)

Emodin alleviates gemcitabine resistance in pancreatic cancer by inhibiting MDR1/P-glycoprotein and MRPs expression
por: Guo, Hongchun, et al.
Publicado: (2020)

Pluronics and MDR Reversal: An Update
por: Alakhova, Daria Y., et al.
Publicado: (2014)

TRAIL sensitize MDR cells to MDR-related drugs by down-regulation of P-glycoprotein through inhibition of DNA-PKcs/Akt/GSK-3β pathway and activation of caspases
por: Seo, Suk-Bin, et al.
Publicado: (2010)

A Cryptic Site of Vulnerability on the Receptor Binding Domain of the SARS-CoV-2 Spike Glycoprotein
por: Joyce, M. Gordon, et al.
Publicado: (2020)

Characterization of the Lipidome and Biophysical Properties of Membranes from High Five Insect Cells Expressing Mouse P-Glycoprotein
por: Moreno, Maria João, et al.
Publicado: (2021)

P-glycoprotein and metallothionein expression and resistance to chemotherapy in osteosarcoma.
por: Shnyder, S. D., et al.
Publicado: (1998)

Residues from Homologous Transmembrane Helices 4 and 10 Are Critical for P-Glycoprotein (ABCB1)-Mediated Drug Transport
por: Rahman, Hadiar, et al.
Publicado: (2023)

ATP-binding cassette subfamily B member 1 (ABCB1) and subfamily C member 10 (ABCC10) are not primary resistance factors for cabazitaxel
por: Kathawala, Rishil J, et al.
Publicado: (2015)

Relationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significance
por: Surowiak, Pawel, et al.
Publicado: (2005)

Beta-Amyloid Downregulates MDR1-P-Glycoprotein (Abcb1) Expression at the Blood-Brain Barrier in Mice
por: Brenn, Anja, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_tbmmleeqdi1d3hgu5if7pugsda